F9 and hemophilia B: Sustained therapeutic factor IX levels were attained after liver-directed gene therapy with AAV vectors in patients with hemophilia B.37,38 We analyzed rAAV DNA carrying the FIX gene (AAV8-AAT-FIXp) as a GOI encapsulated in an AAV8 capsid (Fig. 4D).